PLUS THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Plus Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Plus Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 5.9M shares, a 30.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.9M +1.37M +30.4% Nov 7, 2024 10-Q 2024-11-14
Q2 2024 5.9M +3.02M +105% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 4.28M -32.4M -88.3% Feb 26, 2024 10-K 2024-03-05
Q3 2023 4.52M -29.1M -86.5% Oct 25, 2023 10-Q 2023-10-31
Q2 2023 2.88M -19.7M -87.2% Aug 7, 2023 10-Q 2023-08-14
Q1 2023 36.7M +14.5M +65.3% Apr 18, 2023 10-Q 2023-04-20
Q3 2022 33.6M +18.2M +119% Oct 14, 2022 10-Q 2022-10-20
Q2 2022 22.5M +10.4M +86.4% Jul 14, 2022 10-Q 2022-07-21
Q1 2022 22.2M +1.09M +5.17% Apr 14, 2022 10-Q 2022-04-21
Q3 2021 15.4M +10.6M +221% Oct 15, 2021 10-Q 2021-10-21
Q2 2021 12.1M +7.81M +183% Jul 19, 2021 10-Q 2021-07-22
Q1 2021 21.1M +17.2M +444% Apr 9, 2021 10-Q 2021-04-22
Q3 2020 4.78M +1.01M +26.8% Oct 14, 2020 10-Q 2020-10-22
Q2 2020 4.27M +3.82M +843% Aug 3, 2020 10-Q 2020-08-10
Q1 2020 3.88M -18.3M -82.5% Mar 20, 2020 10-K 2020-03-30
Q3 2019 3.77M -9.43M -71.4% Nov 8, 2019 10-Q 2019-11-14
Q2 2019 453K -7.25M -94.1% Jul 31, 2019 10-Q 2019-08-15
Q1 2019 22.2M -39.5M -64% Apr 30, 2019 10-Q 2019-05-14
Q4 2018 16.3M -43.5M -72.7% Jan 31, 2019 10-K 2019-03-29
Q3 2018 13.2M -21.9M -62.4% Oct 31, 2018 10-Q 2018-11-14
Q2 2018 7.71M -27M -77.8% Jul 31, 2018 10-Q 2018-08-14
Q1 2018 61.6M +29.1M +89.7% Apr 30, 2018 10-Q 2018-05-11
Q4 2017 59.8M +37.9M +172% Jan 31, 2018 10-K 2018-03-09
Q3 2017 35.1M +14.6M +71.3% Oct 31, 2017 10-Q 2017-11-09
Q2 2017 34.7M +14.2M +69.4% Aug 1, 2017 10-Q 2017-08-11
Q1 2017 32.5M +19.1M +144% Apr 30, 2017 10-Q 2017-05-12
Q4 2016 22M -173M -88.7% Jan 31, 2017 10-K 2017-03-24
Q3 2016 20.5M -138M -87.1% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 20.5M -130M -86.4% Jul 31, 2016 10-Q 2016-08-05
Q1 2016 13.3M -112M -89.4% Apr 15, 2016 10-Q 2016-05-10
Q4 2015 195M Jan 31, 2016 10-K 2016-03-11
Q3 2015 158M +66M +71.4% Oct 31, 2015 10-Q 2015-11-06
Q2 2015 151M +71.4M +89.8% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 126M +50.3M +66.7% Apr 30, 2015 10-Q 2015-05-11
Q3 2014 92.4M +25.2M +37.4% Oct 31, 2014 10-Q 2014-11-07
Q2 2014 79.5M +12.3M +18.3% Jul 31, 2014 10-Q 2014-08-11
Q1 2014 75.5M +8.28M +12.3% Apr 30, 2014 10-Q 2014-05-12
Q3 2013 67.3M +8.44M +14.3% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 67.2M +8.52M +14.5% Jul 31, 2013 10-Q 2013-08-09
Q1 2013 67.2M +8.5M +14.5% Apr 30, 2013 10-Q 2013-05-10
Q3 2012 58.8M +3.5M +6.32% Oct 31, 2012 10-Q 2012-11-09
Q2 2012 58.7M +4.91M +9.14% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 58.7M Apr 30, 2012 10-Q 2012-05-10
Q3 2011 55.3M Oct 31, 2011 10-Q 2011-11-08
Q2 2011 53.8M Jul 29, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.